3Aghemo A,Rumi MG,Colombo M.Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C[J].Expert Rev Anti Infect Ther,2009;7(8):925-35.
4Muratori L,Bogdanos DP,Muratori P,et al.Susceptibility to thyroid disorders in hepatitis C[J].Clin Gastroenterol Hepatol,2005;3(6):595-603.
5Ridruejo E,Christensen AF,Mando OG.Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin[J].Eur J Gastroenterol Hepatol,2006;18(6):693-4.
6Zung WWW.The Depression status inventory:an adjunct to the Self-Rating Depression Scale[J].J Clin Psychol,1972;28(4):539-43.
7Katze MG,He Y,Gale M.Viruses and interferon:a fight for supremacy[J].Nat Rev Immunol,2002;2(9):675-87.
8Bonaccorso S,Puzella A,Marino V,et al.Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an inter-correlated stimulation of the cytokine network and an increase in depressive,anxiety symptoms[J].Psychiatry Res,2001;105(1-2):45-55.
9Schaefer M,Schwaiger M,Garkisch AS,et al.Prevention of interferon-alpha associated depression in psychiatric risk patient with chronic hepatitis C[J].J Hepatol,2005;42(6):793-8.
